Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.

Song Xu,Holly Evans,Clive Buckle,K De Veirman,Jinsong Hu,Dehui Xu,Eline Menu,A. De Becker,I Vande Broek,Xavier Leleu,Benjamin Van Camp,Peter I. Croucher,Karin Vanderkerken,I. Van Riet

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.

2012

Song Xu
Holly Evans
Clive Buckle
K De Veirman
Jinsong Hu
Dehui Xu
Eline Menu
A. De Becker
I Vande Broek
Xavier Leleu
Benjamin Van Camp
Peter I. Croucher
Karin Vanderkerken
I. Van Riet

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway

Keywords:

Stem cell transplantation for articular cartilage repair
Cancer research
Fusion gene
Mesenchymal stem cell
Notch signaling pathway
Stem cell
Haematopoiesis
Apoptosis
Biology
Multiple myeloma
Blockade
Internal medicine
Medicine
Hematology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations